Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo

Xiao Wang1,2, Xiumin Wang3,4, Da Teng1,2

  • 1Key Laboratory of Feed Biotechnology, Ministry of Agriculture, Beijing, 100081, P. R. China.

Scientific Reports
|March 11, 2018
PubMed

Insights

Plectasin derivatives MP1102/NZ2114 show promise in treating intracellular Staphylococcus aureus infections, including multidrug-resistant strains. These compounds demonstrated significant efficacy in both cellular and mouse models, outperforming vancomycin in some cases.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Staphylococcus aureus infections are difficult to treat due to intracellular survival and multidrug resistance.
  • Existing treatments face challenges in overcoming intracellular bacterial activity.

Purpose of the Study:

  • To investigate the extracellular and intracellular activities of plectasin derivatives MP1102/NZ2114 against Staphylococcus aureus (MSSA/MRSA).
  • To evaluate the efficacy of MP1102/NZ2114 in cellular and murine models of infection.

Main Methods:

  • Assessed antibacterial activity in a simulated phagolysosomal environment.
  • Investigated cellular uptake mechanisms (clathrin-mediated endocytosis, macropinocytosis).
  • Evaluated efficacy in RAW 264.7 macrophages and mouse models (peritonitis).
  • Measured cytokine regulation (TNF-α, IL-1β, IL-10).

Main Results:

  • MP1102/NZ2114 exhibited potent extracellular activity (>5-log CFU reduction).
  • Intracellular efficacy ranged from 0.42-1.07-log CFU reduction against resistant strains.
  • In a mouse model, MP1102/NZ2114 outperformed vancomycin against MSSA and showed comparable efficacy against MRSA.
  • Activity against a highly virulent strain was notable, though less than vancomycin.

Conclusions:

  • Plectasin derivatives MP1102/NZ2114 demonstrate significant potential for treating intracellular Staphylococcus aureus infections.
  • These compounds offer a promising therapeutic strategy against multidrug-resistant strains.
  • Further development is warranted for MP1102/NZ2114 as anti-staphylococcal agents.

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.7K
Increasing Function01:18

Increasing Function

An increasing function exhibits a rise in output values as input values increase. This behavior is depicted graphically as a curve or line that slopes upward from left to right. Such a function satisfies the condition that if x1 < x2, then f(x1) < f(x2), indicating that the function values grow with increasing inputs. This concept is fundamental in understanding growth trends across various domains, such as population dynamics, financial investments, or resource consumption.The...
403
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
243
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.5K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.2K
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
201.0K